MarketsandMarkets

Next-Gen Digital Pathology Conference

23rd-24th March 2023

ILEC Conference Centre & Ibis London Earls Court, London

Digital Pathology has become a well-established technology.

Globally focused on education, tissue-based research, medication development, and human pathology practice. 

MarketsandMarkets is extremely delighted to announce its “MarketsandMarkets Next-Gen Digital Pathology Conference” scheduled to be held on 23rd-24th March 2023. The conference is designed for having interactive discussions in slide-free imaging, enterprise-wide solutions, and algorithms using machine learning and artificial intelligence that are being developed to improve diagnoses, guide treatment, and address a wide range of medical challenges. The conference provides excellent networking opportunities and interchanging ideas that integrate prompt keynotes, posters, colloquiums, workshops, and the Young Researchers Forum. 

CO-LOCATED CONFERENCES

4th Annual Infectious Disease and Molecular Diagnostics Conference

WHAT TO EXPECT

  • Innovative research in digital pathology
  • Understanding and integrating computational pathology & Cloud computing
  • Critical role of digital pathology and AI in clinical decision making
  • Examining the latest developments in imaging technologies
  • Application of digital pathology in drug discovery
  • Standardisation methods & guidelines- Quality assurance, control, and improvement
  • Machine learning and AI models for improved prediction performance
  • Overcoming challenges in image analysis
  • Use of digital pathology in artificial intelligence for prediction and for better patient identification for appropriate treatment

  • Participate in discussions with experts on how technology implementation can be improved
  • Recognize what digital pathology is and how it can be used in the practice of pathology
  • Attracting and retaining world-class pharma and biotech talent
  • Improve the efficiency of bio-manufacturing by engaging in environmentally sustainable methods
  • Discuss the challenges associated with interfacing a digital pathology system
  • Discover the latest technology implementations in the industry
  • Discover best-in-class solutions during the workshop sessions
  • Interactive panel discussions

  • Pharma/Therapeutics Designation- CEO, COO, Senior scientist, Research scientist, POCT specialist, Presidents, Vice Presidents, Directors, Heads, Managers,
  • Universities Designations- Professors, Researchers, Associate professors, Deans, Senior Professors
  • Hospital Designations - Senior scientist, scientist, pathologist
  • Hospital Laboratories Designations- Pathologists, Lab managers, Lab Directors, Lab technicians
  • Hospitals - Department of Pathology Informatics and Digital Pathology. Department of Haematology, Department of Diagnostics Pathology, Department of Chemical pathology

CONFERENCE AGENDA

Registration

08:15 - 08:50

Welcome note from MarketsandMarkets

08:50 - 08:55

Opening Remarks from the Chairperson

Amal (M.) Asar

Amal (M.) Asar, Consultant Histopathologist, NHS

08:55 - 09:00

Keynote Presentation – Digital Pathology and AI: A new future, An evolving Paradigm for Pathology and Precision Medicine

Radha Krishnan

Radha Krishnan, Executive Director and Clinical Pathology Lead, Merck

09:00 - 09:35

DIGITAL PATHOLOGY – STRATEGY, CHALLENGES AND SCOPE

Panel Discussion: Barriers for AI Adoption in Clinical Practice

Emre Çağatay KÖSE

Emre Çağatay KÖSE, Computational Pathologist, The Institute of Cancer Research

09:35 - 10:10

Pathologists with their Heads in the Cloud; Moving Diagnoses Online

Alistair Robson

Alistair Robson, Medical Director , Source LDPath

10:10 - 10:35

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:35 - 11:20

Veterinary Digital Pathology Research: Bridging the Knowledge Gap

Jonathan Williams

Jonathan Williams, Senior Lecturer, Veterinary Anatomic Pathology, Royal Veterinary College

11:20 - 11:50

Transforming your Lab for Digital Pathology

Prasanth Perugupalli

Prasanth Perugupalli, Chief Product Officer, Pramana

11:50 - 12:20

Digital Pathology in Non-alcoholic steatohepatitis (NASH) Drug Discovery: Opportunity and Challenges?

Hu Sheng Qian

Hu Sheng Qian, Senior Principal Scientist, Boehringer Ingelheim Pharmaceuticals

12:20 - 12:55

Lunch and Poster Presentation | One-to-One Networking Meetings

12:55 - 14:00

Quantification of HBV positive hepatocytes in liver biopsies before and after nucleotide therapy

Jens Brodbeck

Jens Brodbeck, Director, Pathobiology, Gilead Sciences

14:00 - 14:30

ROLE OF PHARMA IN DIGITAL PATHOLOGY

Digital pathology and AI adoption in Multi-modal clinical biomarker development

Qing Li

Qing Li, Director of Clinical Pathology, Moderna

14:30 - 15:00

Evening Refreshments and Poster Presentation | One-to-One Networking Meetings

15:00 - 15:45

Role of digital Pathology in cancer diagnostics

Amal (M.) Asar

Amal (M.) Asar, Consultant Histopathologist, NHS

15:45 - 16:15

Dissection of histopathological analytic workflow and its spatial and clinical relevance in DCIS progression

Priya Narayanan

Priya Narayanan, Analytical Scientist in Digital Pathology and Tissue-based Artificial Intelligence, The Institute of Cancer Research

16:15 - 16:45

For You and Me: Advantages of a Large-Scale Clinical Workflow Together with a Pharma Research Data Repository

Sunil Singhal

Sunil Singhal, Chief of Digital Pathology Transformation, Baylor College of Medicine

16:45 - 17:15

Closing Remarks from the Chairperson

Amal (M.) Asar

Amal (M.) Asar, Consultant Histopathologist, NHS

17:15 - 17:15

Drinks Reception & Networking

17:15 - 17:15

End of Day 1

17:15 - 17:15

Registration

08:15 - 08:50

Welcome note from MarketsandMarkets

08:50 - 08:55

Opening Remarks from the Chairperson

Hu Sheng Qian

Hu Sheng Qian, Senior Principal Scientist, Boehringer Ingelheim Pharmaceuticals

08:55 - 09:00

Towards Safe & Robust AI for Image-guided Diagnosis and Intervention

Mobarakol Islam

Mobarakol Islam, Senior Research Fellow in Medical Image Analysis, University College London

09:00 - 09:35

COMPUTATIONAL PATHOLOGY

Computational Pathology for Precision Medicine

Emre Çağatay KÖSE

Emre Çağatay KÖSE, Computational Pathologist, The Institute of Cancer Research

09:35 - 10:15

Innovative research in digital pathology

Heba Sailem

Heba Sailem, Senior Lecturer in Biomedical AI and Data Science, King’s College London

10:15 - 10:45

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:45 - 11:35

Identification of immune dysregulation triggered by SARS-CoV-2 infection in patients with diagnosed Long COVID

Dr. Benjamin Krishna

Dr. Benjamin Krishna, Associate Principal Investigator, University of Cambridge

11:35 - 12:05

The use of Artificial Intelligence (AI) to optimise patient outcomes in sepsis.

Peter Gayo Munthali

Peter Gayo Munthali, Microbiology Clinical Lead and Antimicrobial & Antifungal Lead, University Hospitals of Coventry

12:05 - 12:35

Artificial Intelligence-based histopathological grading of lung adenocarcinoma

Xiaoxi Pan

Xiaoxi Pan, Postdoctoral Training Fellow, ICR

12:35 - 13:00

Lunch and Poster Presentation | One-to-One Networking Meetings

13:00 - 14:00

AI FOR IMAGING AND DIGITAL IMAGE ANALYSIS

AI-based quantitation of bone marrow fibrosis to improve the assessment and classification of Myeloproliferative Neoplasm (MPN) patients.

Hosuk Ryou

Hosuk Ryou, Postdoctoral Research Assistant, University of Oxford

14:00 - 14:35

Challenges and Advances of Deep Learning in Digital Pathology

Nikolay Burlutskiy

Nikolay Burlutskiy, Director, AI at AstraZeneca

14:35 - 15:05

Closing Remarks from the Chairperson

Hu Sheng Qian

Hu Sheng Qian, Senior Principal Scientist, Boehringer Ingelheim Pharmaceuticals

15:05 - 15:05

Drinks Reception & Networking

15:05 - 15:05

End of the conference

15:05 - 15:05

CONFERENCE SPEAKERS

ADVISORS

Steve Blunden

Steve Blunden

Cellular and Anatomical Pathology Operations Manager, University Hospitals Plymouth NHS Trust

Radha Krishnan

Radha Krishnan

Executive Director and Clinical Pathology Lead, Merck

SPEAKERS

Hu Sheng Qian

Hu Sheng Qian

Senior Principal Scientist, Boehringer Ingelheim Pharmaceuticals

Colin Murphy

Colin Murphy

CEO, mTuitive

Prasanth Perugupalli

Prasanth Perugupalli

Chief Product Officer, Pramana

Sunil Singhal

Sunil Singhal

Chief of Digital Pathology Transformation, Baylor College of Medicine

Qing Li

Qing Li

Director of Clinical Pathology, Moderna

Xiaoxi Pan

Xiaoxi Pan

Postdoctoral Training Fellow, ICR

Emma Robinson

Emma Robinson

Senior Lecturer in Medical Image Analysis, Kings College London

Jonathan Williams

Jonathan Williams

Senior Lecturer, Veterinary Anatomic Pathology, Royal Veterinary College

Mobarakol Islam

Mobarakol Islam

Senior Research Fellow in Medical Image Analysis, University College London

Alistair Robson

Alistair Robson

Medical Director , Source LDPath

Heba Sailem

Heba Sailem

Senior Lecturer in Biomedical AI and Data Science, King’s College London

Radha Krishnan

Radha Krishnan

Executive Director and Clinical Pathology Lead, Merck

Emre Çağatay KÖSE

Emre Çağatay KÖSE

Computational Pathologist, The Institute of Cancer Research

Jens Brodbeck

Jens Brodbeck

Director, Pathobiology, Gilead Sciences

Dr. Benjamin Krishna

Dr. Benjamin Krishna

Associate Principal Investigator, University of Cambridge

Nikolay Burlutskiy

Nikolay Burlutskiy

Director, AI at AstraZeneca

Amal (M.) Asar

Amal (M.) Asar

Consultant Histopathologist, NHS

Peter Gayo Munthali

Peter Gayo Munthali

Microbiology Clinical Lead and Antimicrobial & Antifungal Lead, University Hospitals of Coventry

Priya Narayanan

Priya Narayanan

Analytical Scientist in Digital Pathology and Tissue-based Artificial Intelligence, The Institute of Cancer Research

Hosuk Ryou

Hosuk Ryou

Postdoctoral Research Assistant, University of Oxford

ENQUIRE NOW

SPONSORS

PARTNERS

LOCATION

Venue

ILEC Conference Centre & Ibis London Earls Court, London

PAST EVENT GALLERY